Skip to content

13F-HR filed by Partner Investment Management, L.P.

Partner Investment Management, L.P. filed this 13F-HR for the quarter ended 2019-12-31, filed 2020-02-14, with 41 holding rows worth $13,928,000.

Accession
0001104659-20-022007
Filed
2020-02-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2019

A holdings report, 41 entries on the cover page, a total value of $13,928,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $13,928,000 with VALUE read as thousands by filing date, 13F file number 028-13168. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
AUDENTES THERAPEUTICS INC.05070R104Common Stock17,795$1,065,000thousands by filing date
ALEXION PHARMACEUTICALS INC015351109COM8,421$911,000thousands by filing date
Allena Pharmaceuticals, Inc.018119107COM284,285$776,000thousands by filing date
Gilead Sciences,Inc.375558103COM10,898$708,000thousands by filing date
PENUMBRA INC COM70975L107Stock3,699$608,000thousands by filing date
ZIMMER BIOMET HOLDINGS INC COM98956P102Stock3,689$552,000thousands by filing date
BIOGEN INC COM09062X103Stock1,839$546,000thousands by filing date
NEVRO CORP64157F103COM4,515$531,000thousands by filing date
Elevance Health, Inc.036752103COM1,669$504,000thousands by filing date
HUMANA INC COM444859102Stock1,347$494,000thousands by filing date
Cigna Corporation125523100COM2,216$453,000thousands by filing date
IQVIA HLDGS INC COM46266C105Stock2,926$452,000thousands by filing date
BIOMARIN PHARMACEUTICAL INC09061G101COM5,329$451,000thousands by filing date
ALLERGAN PLCG0177J108SHS2,282$436,000thousands by filing date
AERIE PHARMACEUTICALS INC00771V108COM18,035$436,000thousands by filing date
ARENA PHARMACEUTICALS INC040047607COM NEW9,484$431,000thousands by filing date
CENTENE CORP DEL COM15135B101Stock6,838$430,000thousands by filing date
NOVARTIS AG SPONSORED ADR66987V109ADR4,270$392,000thousands by filing date
HCA Healthcare Inc40412C101COM2,335$345,000thousands by filing date
Pfizer Inc.717081103COM7,492$294,000thousands by filing date
ICU MED INC44930G107COM1,381$258,000thousands by filing date
DERMIRA INC24983L104COM16,892$256,000thousands by filing date
ICON PUB LTD CO SHSG4705A100Stock1,402$241,000thousands by filing date
UnitedHealth Group Inc91324P102COM791$233,000thousands by filing date
IRHYTHM HOLDINGS INC COM450056106Stock3,389$231,000thousands by filing date
IMMUNOMEDICS INC452907108COM10,880$230,000thousands by filing date
Abbott Laboratories002824100COM2,565$223,000thousands by filing date
MOLINA HEALTHCARE INC60855R100COM1,387$188,000thousands by filing date
EDWARDS LIFESCIENCES CORP COM28176E108Stock788$184,000thousands by filing date
STANDARD BIOTOOLS INC34385P108COM37,856$132,000thousands by filing date
CATALENT INC USD 0.01148806102COM2,231$126,000thousands by filing date
MorphosysD55040105COM994$126,000thousands by filing date
AbbVie,Inc.00287Y109COM1,269$112,000thousands by filing date
AXONICS INC05465P101COM3,978$110,000thousands by filing date
CARDIOVASCULAR SYSTEMS INC141619106COMMON STOCK1,985$96,000thousands by filing date
Vertex Pharmaceuticals Incorporated92532F100COM434$95,000thousands by filing date
HALOZYME THERAPEUTICS INC COM40637H109Stock4,650$82,000thousands by filing date
AMARIN CORP PLC023111206SPONS ADR NEW3,757$81,000thousands by filing date
COHERUS ONCOLOGY INC19249H103COM3,771$68,000thousands by filing date
ACORDA THERAPEUTICS INC00484M106COM18,342$37,000thousands by filing date
ENDOLOGIX INC29266S304COM NEW2,440$4,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001104659-20-022007this filing2020-02-14acceptance time not in the bulk data set